Clinical Trial Update: Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic Rhinoconjunctivitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of Grass Pollen Allergoid for grass pollen allergy has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Grass Pollen Allergy

Drugs mentioned

• Grass Pollen Allergoid

Snippet

Sponsor: Allergopharma GmbH & Co. KG | Conditions: Grass Pollen Allergy | Phase 3 | Status: COMPLETED